Jonathan G Pol - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Jonathan G Pol

Showing results (51-60 of 53) with videos related to

Pageof 6

Sort By:

You have reached the last page of results.This site can display upto 53 results.

Molecular Cancer|September 6, 2024

Acyl-coenzyme a binding protein (ACBP) - a risk factor for cancer diagnosis and an inhibitor of immunosurveillanceLéa Montégut, Peng Liu, Liwei Zhao, et al.

Molecular Cancer|October 17, 2024

Correction: Acyl-coenzyme a binding protein (ACBP) - a risk factor for cancer diagnosis and an inhibitor of immunosurveillanceLéa Montégut, Peng Liu, Liwei Zhao, et al.

The Journal of Experimental Medicine|September 8, 2021

Autoimmunity affecting the biliary tract fuels the immunosurveillance of cholangiocarcinomaJuliette Paillet, Céleste Plantureux, Sarah Lévesque, et al.

Pageof 6

Search research articles

Showing results (51-60 of 53) with videos related to

Sort By:

Pageof 6

You have reached the last page of results.This site can display upto 53 results.

Molecular Cancer|September 6, 2024

Acyl-coenzyme a binding protein (ACBP) - a risk factor for cancer diagnosis and an inhibitor of immunosurveillanceLéa Montégut, Peng Liu, Liwei Zhao, et al.

Molecular Cancer|October 17, 2024

Correction: Acyl-coenzyme a binding protein (ACBP) - a risk factor for cancer diagnosis and an inhibitor of immunosurveillanceLéa Montégut, Peng Liu, Liwei Zhao, et al.

The Journal of Experimental Medicine|September 8, 2021

Autoimmunity affecting the biliary tract fuels the immunosurveillance of cholangiocarcinomaJuliette Paillet, Céleste Plantureux, Sarah Lévesque, et al.

Pageof 6